AVTOZMA 162 mg/0.9 ml sol inj 162 mg 4 pce

7680698550020 CH-69855 L04AC07 07.15.0.

Active substances:

Tocilizumabum

No images available

Details

Product number
6985501
CPT
-
Packaging group
4
Unit
Injektor(en), vorgefüllt/Pen
Composition
tocilizumabum 162 mg, histidinum, histidini hydrochloridum monohydricum, methioninum, threoninum, polysorbatum 80, aqua ad iniectabile q.s., ad solutionem pro.

Articles (1)

Avtozma 162 mg/0.9 ml, solution injectable en stylo prérempli
Lösung
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/04/2026
Patient information leaflet
Français
18/04/2026
Patient information leaflet
Italien
18/04/2026

Detailed composition

Substance Quantity Type Category
tocilizumabum
162.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
methioninum
- Substance HNIDK
threoninum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 697.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
69855
Drug name
Avtozma, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
L04AC07
Authorization status
Z
Dispensation category
A
First authorization
20/06/2025
Authorization expiration date
19/06/2030
IT number
07.15.0.
Domain
Human medicine

Packaging details

Description (FR)
AVTOZMA 162 mg/0.9 ml sol inj 162 mg 4 pce
Description (DE)
AVTOZMA 162 mg/0.9 ml Inj Lös 162 mg 4 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data